bsm-60738R-RBITC [Conjugated Primary Antibody]
Ki-67 Recombinant Antibody, RBITC Conjugated
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: Ki-67

Clonality: Recombinant

Isotype: IgG

Entrez Gene: 4288

Swiss Prot: P46013

Source: KLH conjugated synthetic peptide derived from human Ki67

Purification: purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Ki67 antigen is the prototypic cell cycle related nuclear protein, expressed by proliferating cells in all phases of the active cell cycle (G1, S, G2 and M phase). It is absent in resting (G0) cells. Ki67 antibodies are useful in establishing the cell growing fraction in neoplasms (immunohistochemically quantified by determining the number of Ki67 positive cells among the total number of resting cells = Ki67 index). In neoplastic tissues the prognostic value is comparable to the tritiated thymidine labelling index. The correlation between low Ki67 index and histologically low grade tumours is strong. Ki67 is routinely used as a neuronal marker of cell cycling and proliferation.

Conjugation: RBITC

Excitation/ Emission: 570nm/595nm

Size: 100ul

Concentration: 1mg/ml

Applications: IHC-F(1:100-500)
IHC-P(1:100-500)
ICC/IF(1:100-500)
IF(1:100-500)
Flow-Cyt(1ug/Test)

Predicted Molecular Weight: 358 kDa


Cross Reactive Species: Human
Mouse
Rat

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Yan Du. et al. Targeting SDCBP2 in acute myeloid leukemia. CELL SIGNAL. 2023 Sep;:110889Read more>>
  • Xiang Guo. et al. GPR168 functions as a tumor suppressor in mouse melanoma by restraining Akt signaling pathway. PLOS ONE. 2024 May;19(5):e0302061Read more>>
  • Li Kangkang. et al. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy. J NANOBIOTECHNOL. 2024 Dec;22(1):1-23Read more>>
  • Haijiao Wang. et al. Catalase-positive Staphylococcus epidermidis based cryo-millineedle platform facilitates the photo-immunotherapy against colorectal cancer via hypoxia improvement. J COLLOID INTERF SCI. 2024 Dec;676:506Read more>>
VALIDATION IMAGES